PLOS Global Public Health · 2024 · 10 citations · 23 references
Public HealthChronic Disease PreventionPharmacoeconomicsCost-effectiveness AnalysisPopulation HealthTobacco ControlChronic DiseaseChronic Disease Risk ReductionCost-effectiveness ComparisonDisease BurdenDisease Prevention StrategiesNoncommunicable Disease PreventionBurden Of Communicable DiseasesBurden Of Disease ModelingChronic Disease Cost ModelingCommunicable Disease BurdenCost-effectiveness MicrosimulationDisease Burden ComparisonHypertension DiagnosisTobacco Smoking
We sought to assess the effectiveness and cost-effectiveness of potential new public health and healthcare NCD risk reduction efforts among Palestinians in Gaza. We created a microsimulation model using: (i) a cross-sectional household survey of NCD risk factors among 4,576 Palestinian adults aged ≥40 years old in Gaza; (ii) a modified Delphi process among local public health experts to identify potentially feasible new interventions; and (iii) reviews of intervention cost and effectiveness, modified to the Gazan and refugee contexts. The survey revealed 28.6% tobacco smoking, a 40.4% prevalence of hypertension diagnosis (with a 95.6% medication treatment rate), a 25.6% prevalence of diabetes diagnosis (with 95.3% on treatment), a 21.9% prevalence of dyslipidemia (with 79.6% on a statin), and a 9.8% prevalence of asthma or chronic obstructive pulmonary disease (without known treatment). A calibrated model estimated a loss of 9,516 DALYs per 10,000 population over the 10-year policy horizon. The interventions having an incremental cost-effectiveness ratio (ICER) less than three times the GDP per capita of Palestine per DALY averted (<$10,992 per DALY averted)(<$10,992 per DALY averted) included bans on tobacco smoking in indoor and public places [$34 per incremental DALY averted (95% CI: $17, $50)], treatment of asthma using low dose inhaled beclometasone and short-acting beta-agonists [$140 per DALY averted (95% CI: $77, $207)], treatment of breast cancer stages I and II [$730 per DALY averted (95% CI: $372, $1,100)], implementing a mass media campaign for healthier nutrition [$737 per DALY averted (95% CI: $403, $1,100)], treatment of colorectal cancer stages I and II [$7,657 per DALY averted (95% CI: $3,721, $11,639)], and (screening with mammography [$17,054 per DALY averted (95% CI: $8,693, $25,359)]). Despite high levels of NCD risk factors among Palestinians in Gaza, we estimated that several interventions would be expected to reduce the loss of DALYs within common cost-effectiveness thresholds.
23
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt et al. · PLoS Medicine · 2021 · 4.9K citations · Full text
Jaana Lindström, Jaakko Tuomilehto · Diabetes Care · 2003 · 1.9K citations · Full text
Medicine, Chronic Disease Prevention, Preventive Medicine +15